Device manufacturer, as written on reports

Pacesetter: medical device reports filed with FDA

1,863 reports name it as the manufacturer of the device involved, 1995–2025.

Read first · FDA's statement on these data

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product. openFDA, FDA

FDA adds: "Although MDRs are a valuable source of information, this passive surveillance system has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data. In addition, the incidence or prevalence of an event cannot be determined from this reporting system alone due to potential under-reporting of events and lack of information about frequency of device use." And: "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices."

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

1,863
reports naming it as manufacturer: 0% of all MAUDE reports; 0
reports, 12 months to August 2026: 3 in the 12 months before; 36.9%
classified as malfunction: 62.3% across all reports; 0.4%
classified as death, as reported: 0.9% across all reports

1,863 medical device reports received by FDA give Pacesetter as the manufacturer of the device involved, 0% of the MAUDE database, from July 1995 to July 2025. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.

0 reports arrived in the 12 months to August 2026, against 3 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (62.5%), malfunction (36.9%) and death (0.4%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands named most often

Brand	Device type	Reports	Latest 12 months	Classified as death
Permanent Pacemaker Electrode	Permanent pacemaker electrode	178	332	0.4%
Passive Plus	Permanent pacemaker electrode	87	5	1.1%
Active Fixation Endocardial Lead	Permanent pacemaker electrode	79	0	0.7%
Bipolar Ventricular Endocardial Lead	Permanent pacemaker electrode	60	1	1%
Trilogy	Ventilator, continuous, facility use	51	663	0.4%
Active Fixation Lead	Permanent pacemaker electrode	44	0	1.8%
Phoenix	Dialyzer, high permeability with or without sealed dialysate system	43	16	5.5%
Drug Eluting Permanent Right Ventricular Rv Or Right Atrial Ra Pacemaker Ele	Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes	38	405	0.3%
Bipolar Endocardial Lead	Permanent pacemaker electrode	32	0	0.6%
Pulse Generator Permanent Implantable	Pulse generator, permanent, implantable	24	24	1.1%
Tendril Dx	Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes	21	69	2%
Implantable Cardioverter Defibrillator Non-Crt	Implantable cardioverter defibrillator (non-crt)	17	197	0.5%
Meta Dddr	Implantable pacemaker pulse-generator	17	0	0.4%
Tendril	Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes	14	10	1.4%
Synchrony	Implant, cochlear	10	490	0%
Lead	Permanent pacemaker electrode	7	118	0.5%
Implantable Pacemaker Pulse-Generator	Implantable pacemaker pulse-generator	3	9	0.6%
Permanent Defibrillator Electrodes	Permanent defibrillator electrodes	3	230	0.6%
Ra Lead	Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes	3	61	0.2%
Tendril Sdx	Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes	3	3	2.3%
Defibrillator Automatic Implantable Cardioverter With Cardiac Resynchronizatio	Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d)	2	50	1%
Drug Eluting Permanent Left Ventricular Lv Pacemaker Electrode	Drug eluting permanent left ventricular (lv) pacemaker electrode	1	80	0.3%
Riata	Implantable cardioverter defibrillator (non-crt)	1	7	0.4%
Rv Lead	Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes	1	142	0.3%
Viva Quad XT CRT-D	Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d)	1	24	2%

Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Device types

Product code	Device type	Reports	Share
DTB	Permanent pacemaker electrode	895	48%
DXY	Implantable pacemaker pulse-generator	838	45%
NVN	Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes	58	3.1%
NVZ	Pulse generator, permanent, implantable	30	1.6%
LWS	Implantable cardioverter defibrillator (non-crt)	29	1.6%
LWP	Implantable pulse generator, pacemaker (non-crt)	8	0.4%
NVY	Permanent defibrillator electrodes	5	0.3%
NIK	Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d)	2	0.1%
LDF	Electrode, pacemaker, temporary	1	0.1%
OJX	Drug eluting permanent left ventricular (lv) pacemaker electrode	1	0.1%

Reports by month, five years

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type

Death0.4%7

Injury62.5%1,164

Malfunction36.9%687

Other0.1%2

Not given0.2%3

Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.

Questions about Pacesetter reports

How many FDA device reports name Pacesetter as manufacturer?

1,863 reports through August 2026, 0 of them in the latest 12 months.

Which of its brands appear most often?

Permanent Pacemaker Electrode (178), Passive Plus (87), Active Fixation Endocardial Lead (79), Bipolar Ventricular Endocardial Lead (60) and Trilogy (51).

Which device types does it report on?

permanent pacemaker electrode (48%), implantable pacemaker pulse-generator (45%), drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes (3.1%) and pulse generator, permanent, implantable (1.6%).

Does a high count say something about the manufacturer?

Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.